What is the 3-Pyridyl bromide?

3-Pyridyl bromide is clear colourless to yellow liquid, while it's Molecular Formula is C5H4BrN. clear colourless to yellow liquid 3-Bromopyridine undergoes lithiation with LDA at low temperatures in the 4-position: Heterocycles, involved in formation of the Grignard by Mg exchange with i-PrMgCl and in transmetallation of the lithiated derivative with zinc chloride followed by treatment with an electrophile as a route to 4-substituted 3-bromopyridines.

What is the CAS number for 3-Pyridyl bromide?

The CAS number of 3-Pyridyl bromide is 626-55-1.

What is 3-Pyridyl bromide (626-55-1) used for?

3-Pyridyl bromide, also known as 3-bromopyridine, is a monobromopyridine in which the bromo substituent is located at position 3. It is a clear colorless to yellow liquid and is commonly used in various chemical reactions and applications due to its unique chemical properties.InChI:InChI=1/C5H4BrN/c6-5-2-1-3-7-4-5/h1-4H

What is the 3-Pyridyl bromide?

3-Pyridyl bromide is clear colourless to yellow liquid, while it's Molecular Formula is C5H4BrN. clear colourless to yellow liquid 3-Bromopyridine undergoes lithiation with LDA at low temperatures in the 4-position: Heterocycles, involved in formation of the Grignard by Mg exchange with i-PrMgCl and in transmetallation of the lithiated derivative with zinc chloride followed by treatment with an electrophile as a route to 4-substituted 3-bromopyridines.

What is the CAS number for 3-Pyridyl bromide?

The CAS number of 3-Pyridyl bromide is 626-55-1.

What is 3-Pyridyl bromide (626-55-1) used for?

3-Pyridyl bromide, also known as 3-bromopyridine, is a monobromopyridine in which the bromo substituent is located at position 3. It is a clear colorless to yellow liquid and is commonly used in various chemical reactions and applications due to its unique chemical properties.InChI:InChI=1/C5H4BrN/c6-5-2-1-3-7-4-5/h1-4H

Your Location：Home > Products > Pharmaceutical > 626-55-1

Product classification

626-55-1

Product Name：3-bromopyridine
Molecular Formula：C₅H₄BrN
Purity：99%
Molecular Weight：157.997

Inquiry

Product Details

pd_meltingpoint:-27 °C

Appearance:clear colourless to yellow liquid

Purity:99%

Factory Sells Best Quality 3-bromopyridine 626-55-1 with USP

Molecular Formula:C5H4BrN
Molecular Weight:157.997
Appearance/Colour:clear colourless to yellow liquid
Vapor Pressure:2.16mmHg at 25°C
Melting Point:-27 °C
Refractive Index:n20/D 1.571(lit.)
Boiling Point:168.2 °C at 760 mmHg
PKA:2.84(at 25℃)
Flash Point:51.7 °C
PSA：12.89000
Density:1.598 g/cm³
LogP:1.84410

3-Pyridyl bromide(Cas 626-55-1) Usage

Synthesis Reference(s)	Synthesis, p. 293, 1974 DOI: 10.1055/s-1974-23300
Definition	ChEBI: A monobromopyridine in which the bromo substituent is located at position 3.

InChI:InChI=1/C5H4BrN/c6-5-2-1-3-7-4-5/h1-4H

Company Profile

Bailong Pharmaceutical officially began operations in 2017, located in the High-tech Zone of Jinan City. It is a high-tech enterprise specializing in the research and production of chemical raw materials and advanced pharmaceutical intermediates, and has currently passed the GB/T 19001-2016/ISO 9001 quality management system certification standards. The company is dedicated to serving major pharmaceutical companies, fine chemical production units, large pharmaceutical research and development centers, and other users of pharmaceutical chemicals both domestically and internationally. It has established cooperation with nearly all of the top ten pharmaceutical companies in the country and hundreds of small and medium-sized biotechnology companies, providing specialized services such as the supply of commercial chemicals, technical research and development, production technology outsourcing, and customized chemicals. In 2020, it was included in the list of "Top Ten Suppliers of the Year" for certain A-share listed companies, reaching a long-term cooperation intention to help clients improve production capacity and development efficiency, and push the project to market at full speed.

Development History

2020yearThe application for Shandong high-end pharmaceutical intermediates production base was successful, and it was officially put into operation in June 2022
2021yearIn the first quarter, the growth rate reached a new high, with a year-on-year increase of 210%, achieving leapfrog growth in the new fiscal year
2022yearIn December,the independent R&D laboratory building of Yinfeng Bio-City was put into operation to help product R&D and innovation.